Oral drug delivery company, IntelGenx, has appointed André Godin to the position of president in addition to his current position as the company’s chief financial officer.    In his newly expanded role, Mr. Godin will have overall responsibility for day-to-day operations, financial reporting and budgeting, as well as managing the company’s relationships and interactions with the investment community. He will continue to report to the company’s chief executive officer, Horst Zerbe.   “In th...